In the race against the virus, hours and minutes matter
The latest twist in the COVID-19 pandemic is the alarming emergence of new SARS-CoV-2 variants of concern, such as lineages B.1.351, P1 and B.1.1.7. The potential for new variants to evade the immune response, lowering the efficacy of vaccines remains a threat. Labs are therefore under pressure to sequence samples as quickly as possible to identify new and catalog existing SARS-CoV-2 variants circulating in the population. To help you accelerate your SARS-CoV-2 genomic surveillance efforts, we’ve developed two tailored solutions for viral amplification and NGS library preparation.
Get the right genomic surveillance solution for your needs
The faster you can sequence samples, the quicker you can develop a comprehensive picture of circulating variants, allowing you to stay one step ahead. Explore how our genomic surveillance solutions can help.
Fast, high-throughput NGS solution
Why choose the QIAseq DIRECT SARS-CoV-2 Kit?
Use our ultrafast, high-throughput, single-box NGS solution if you want to maximize efficiency, ramp up your sequencing capability and ensure superior coverage to accelerate variant detection.
-
4-hourenrichment and library prep workflow that can be automated, allowing you to go from purified RNA to sequence – no need for fragmentation, tagmentation or ligation steps.
-
~250 bpamplicons generated for superior uniformity and better coverage across the SARS-CoV-2 genome and better sequencing performance compared with the most widely-used amplicon-based options.
-
Up to 768samples can be multiplexed to improve scalability and efficiency.
-
50%reduction in plasticware usage.
Optimized ARTIC-based NGS solution
QIAseq SARS-CoV-2 Primer Panel
Expedite SARS-CoV-2 variant detection and real-time genomic surveillance with our scalable, single-day workflow, which is faster and has lower-input requirements than hybrid capture solutions. Based on optimized publicly available ARTIC V3 designs, the QIAseq SARS-CoV-2 Primer Panel provides targeted enrichment of the complete viral genome, allowing you to:
- Achieve high coverage, even at low copy number due to reduced primer dropouts and primer-dimer effects
- Multiplex up to 384 samples in a single run on high-throughput Illumina platforms
- Track and visualize phylogenetic divergence with integrated bioinformatics analysis pipelines
A winning combination for improved scalability
Combine the QIAseq SARS-CoV-2 Primer Panel with the QIAseq FX DNA Library UDI Kit to multiplex up to 384 samples in a single run.
-
QIAseq SARS-CoV-2 Primer PanelTargeted whole genome library preparation of SARS-CoV-2 for genomic surveillance and variant detection -
QIAseq FX DNA Library UDI KitAll-enzymatic whole genome and hybrid capture library preparation for Illumina instruments with minimal bias
Get started with a trial kit
-
QIAseq SARS-CoV-2 Primer Panel Kit
-
QIAseq FX DNA Library UDI Kit
Publications
Check out our webinars
Dive deeper
-
SARS-CoV-2 Whole Genome Sequencing ServicesRamp up SARS-CoV-2 genomic surveillance efforts by taking advantage of our comprehensive SARS-CoV-2 Whole Genome Sequencing Services. Extend your in-house resources with the expertise and custom services that you expect from QIAGEN. -
Analyze SARS-CoV-2 sequence data with easeMake sense of your SARS-CoV-2 sequencing data with integrated bioinformatics. Intuitive and easy-to-use QIAGEN CLC Genomics Workbench enables visualization and comparison of multiple reads and variants simultaneously. The new QIAGEN CoV-2 Insights Service now offers a low-cost, highly-scalable cloud infrastructure for distributed processing, analysis and reporting of SARS-CoV-2 variants and lineages. From phylogenetic to metagenomic analyses, accelerate impactful insights with our integrated bioinformatics solutions for SARS-CoV-2 genomic surveillance.